University of Warwick Strengthens Global Health Research with New Funding for Virus Replication Studies

University of Warwick Strengthens Global Health Research with New Funding for Virus Replication Studies

(IN BRIEF) University of Warwick researcher Dr Jeremy Keown has received funding through the Academy of Medical Sciences’ Springboard programme, which is investing £6.7 million in early-career health research across the UK. His project will investigate how potentially pandemic viruses replicate at the molecular level, with the goal of supporting the development of new antiviral therapies and improving global preparedness for future health emergencies. The Springboard programme, now in its eleventh year, provides critical support for researchers establishing independent careers and has funded hundreds of scientists across dozens of institutions. Backed by organisations including the UK Government, Wellcome, and the British Heart Foundation, the initiative plays a key role in advancing discovery-driven research into major health challenges such as infectious diseases and chronic conditions.

(PRESS RELEASE) COVENTRY, 15-Apr-2026 — /EuropaWire/ — University of Warwick has secured national recognition for its research efforts after Dr Jeremy Keown, an Assistant Professor in the School of Life Sciences, was awarded funding through the Academy of Medical Sciences’ Springboard programme. The initiative is supporting 55 early-career researchers across the UK as part of a £6.7 million investment aimed at advancing discovery-led health research.

Dr Keown’s project will focus on understanding how potentially pandemic viruses replicate at the molecular level. This area of study is considered essential for the development of new antiviral treatments and for strengthening preparedness against future global health threats. The research contributes to the University of Warwick’s broader commitment to addressing complex international health challenges through scientific innovation.

He explained that the funding will allow his research group to explore the mechanisms that enable viruses with pandemic potential to reproduce within host cells. By uncovering these processes, the work aims to establish a scientific foundation for developing urgently needed antiviral therapies and to enhance global efforts to respond effectively to emerging infectious diseases.

The Springboard programme is designed to support researchers at a critical early stage in their careers, providing them with the resources needed to establish independent research programmes and pursue ambitious, curiosity-driven projects. These initiatives often form the basis for future medical breakthroughs and therapeutic advancements.

Since its launch over a decade ago, the programme has played a significant role in strengthening the UK’s research landscape. Now in its eleventh year, it has supported 471 researchers across 68 institutions, with total funding exceeding £50.5 million since 2015. The current round of awards is supported by contributions from the UK Government, Wellcome, and the British Heart Foundation, covering a broad spectrum of health challenges including infectious diseases, neurodegenerative conditions, and chronic pain.

Patrick Vallance highlighted the importance of investing in early-stage research, noting that supporting scientists at this phase helps bridge the gap where commercial funding can be difficult to secure. He emphasised that such investments are vital for advancing discoveries that can improve health outcomes both in the UK and internationally.

Dr Keown’s award reflects the University of Warwick’s continued focus on impactful research, particularly in areas that address global health risks. By advancing understanding of viral replication, the project aims to contribute to international efforts to better prepare for and mitigate future pandemics.

About the University of Warwick 

Founded in 1965, the University of Warwick is a world-leading institution known for its commitment to era-defining innovation across research and education. A connected ecosystem of staff, students and alumni, the University fosters transformative learning, interdisciplinary collaboration and bold industry partnerships across state-of-the-art facilities in the UK and global satellite hubs. Here, spirited thinkers push boundaries, experiment and challenge convention to create a better world.

Media Contact:

Matt Higgs, PhD
Media & Communications Officer (Warwick Press Office)
Email: Matt.Higgs@warwick.ac.uk
Phone: +44(0)7880 175403

SOURCE: University of Warwick